MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) terminated its proposed sale of an Ontario facility to Kensana Health after the buyer failed to meet certain conditions, the company announced Monday.
The deal, originally announced in December, would have sold MediPharm’s Napanee facility for C$5.5 million through the sale of subsidiary ABcann…
Please login to read all 261 words.
